Navigation Links
Jazz Pharmaceuticals and Azur Pharma Agree to Combine to Form Jazz Pharmaceuticals plc
Date:9/19/2011

PALO ALTO, Calif. and DUBLIN, Sept. 19, 2011 /PRNewswire/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) and Azur Pharma Limited today announced that the companies have agreed to combine in an all-stock transaction that creates a specialty pharmaceutical company incorporated in Ireland with a diversified portfolio of products currently marketed in the United States (US).  The combined company would be named Jazz Pharmaceuticals plc.

Azur Pharma is a privately-held, profitable specialty pharmaceutical company headquartered in Dublin, Ireland with US operations in Philadelphia.  The company markets ten specialty pharmaceutical products in the US in the central nervous system (CNS) and women's health areas, with expected 2011 net sales of approximately $95 to $100 million.  

"This significant transaction represents a compelling strategic fit, given our companies' closely aligned missions of identifying and developing products that address unmet patient needs and can be efficiently marketed through a specialty commercial infrastructure," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals.  "Our combined organizations would have a diverse portfolio of products and an international platform, paving the way for long term growth that builds on our current strengths.  We look forward to working with our colleagues at Azur Pharma to join our two companies into one that is even stronger, creating value for our stockholders while serving more patients."

Seamus Mulligan, chairman and chief executive officer of Azur Pharma added, "This combination brings together two successful businesses and cultures in a larger company better situated to compete in the specialty pharmaceutical sector. The combined company would have greater operational and financial resources to enable its strategy to acquire and develop important special
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
2. Cempra Pharmaceuticals Presents New Data on its Fourth Generation Macrolide, Solithromycin (CEM-101) at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
3. Jazz Pharmaceuticals Announces Presentation at the UBS Global Life Sciences Conference in New York on September 20
4. Avanir Pharmaceuticals to Participate in Two Investor Conferences
5. Qualitest Pharmaceuticals Issues a Nationwide Voluntary Recall of Oral Contraceptives
6. Oramed Pharmaceuticals Chosen to Present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011
7. Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
8. AcelRx Pharmaceuticals to Present at Two Healthcare Investor Conferences in the Second Half of September
9. Vanda Pharmaceuticals to Participate in UBS Global Life Sciences Conference
10. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
11. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Virginia , 11. Juli 2014 ... von Kameras für die molekulare Bildgebung, ... hat heute die CE-Zulassung für sein ... CE-Zeichen kann Dilon das Produkt jetzt ... auf den Großteil der europäischen Länder ...
(Date:7/10/2014)... 2014  Breg, Inc., a premier provider of ... FreeRunner™ knee brace with new innovations to help ... return to active lifestyles.  FreeRunner,s patent-pending design acts ... support when patients need it most, and the ... Patellofemoral issues are the most common cause ...
(Date:7/10/2014)... , July 10, 2014  RESMED INC. (NYSE: ... quarter and fiscal year ended June 30, 2014 results on ... market close. A press release with ResMed,s results will be ... will host a webcast to discuss operating results and future ... at 1:30 p.m. US Pacific Time and the live webcast ...
Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... technology has enabled more and more laboratory testing to ... laboratory is hardly threatened with extinction. National volume data ... ever before, and the huge range of their capabilities, ... volumes of tests assures them an abiding and pivotal ...
... S. Singer, M.D., Ph.D. Harvard Medical School ,Contributing ... and 40,000 deaths per year, breast cancer undoubtedly ... problems. Recently, efforts to develop early detection ... progress. This is particularly true at the ...
Cached Medicine Technology:Immunoassay Systems - Your Laboratory Workhorse 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 3
(Date:7/11/2014)... 11, 2014 As transvaginal mesh ... Johnson & Johnson’s Ethicon Inc. unit continue to ... that the Texas Attorney General’s Office has acknowledged ... surgical mesh products used to treat pelvic organ ... report from kens5.com, the probe began nearly two ...
(Date:7/11/2014)... (HealthDay News) -- People with the lowest incomes may have ... disease (PAD), a new study suggests. People with PAD ... limbs, most often the legs. The condition causes leg pain ... throughout the body. People with PAD have a higher risk ... nearly 6,800 people with PAD who took part in the ...
(Date:7/11/2014)... UK (PRWEB) July 11, 2014 Microbiology ... of the in-vitro diagnostics industry, which is expected to ... ten years. The sector owes its growth to the ... to people’s health worldwide and a major factor leading ... technologies, threat of bio-terrorism, and a broader availability of ...
(Date:7/11/2014)... The Europe Well Intervention Market report defines ... analysis and revenue forecast. The well intervention services market in ... 2013 to $3.4 billion by 2018, at a CAGR of ... of the Europe Well Intervention Market report, to get an ... glimpse of the segmentation in the Europe well intervention market, ...
(Date:7/11/2014)... MA (PRWEB) July 11, 2014 ... at least $50 billion in fuel costs ... immediately. The current GHG standards ... have taken it upon themselves to install ... include: , 1.    Idle reduction technologies , 2.    Efficient ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 2Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 4Health News:Poor More Prone to Leg Circulation Trouble 2Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 2Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 3Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 2Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 3
... Oriental medical practice of Acupuncture along with commonly ... disabling side effects of chemotherapy for breast cancer ... (NIH) are to be believed. , , ,According ... NIH, electro-acupuncture was more effective in controlling vomiting ...
... causing 160,000 deaths annually from lung, mouth, bladder and other ... of the colon or rectum, according to results of a ... ,As many as 12% of all colorectal cancer deaths in ... cancer is not currently considered a smoking-related cancer, but data ...
... is often difficult to diagnose and many a times ... reaction (PCR) is emerging as a promising technique for ... of bacteria by facilitating rapid amplification of small amounts ... the Millennium International Urology Congress in India. Presence ...
... prescription drug, levothyroxine sodium (Unithroid) for hypothyroidism in adults ... States by the FDA. , ,The thyroid hormaone ... metabolic processes within the body in all age groups. In ... intellectual development. , ,Low levels of thyroid hormone or ...
... has become an ever-growing menace on the Internet. ... have listed 500 health related web-sites that are ... serve as a guideline for surfers to be ... sites. The information can be accessed on http://www.ratbags.com/rsoles/categories.htm, ...
... after the start of an El Ni?o event in ... ,Bangladesh can expect a surge of cholera cases, according ... with subsequent ,cholera outbreaks. , ,Details of the ... of the journal Science by ecologists at Cornell University ...
Cached Medicine News:Health News:El Ni?o cycles linked to cholera outbreaks , 2
The PDC Smart® Key Fob can be programmed on demand using a 13.56 MHz RFID reader/writer and is ideal for long-term use applications such as electronic access control or loyalty programs....
... provide healthcare professionals witha patient'sname and ... speak, cant remember, oris unconscious. VeriMed ... individuals. The application can help these ... comparable level of care by rapidly ...
... The optional Kisses component of ... to assist nursing staff in ... while in the hospital. ... have an easy, effective and ...
VerdaSee Portal ID is a family of solutions that provide automated tracking and tracing of assets as they enter or leave designated areas within a healthcare facility....
Medicine Products: